StemCells, Inc. Announces 1-for-12 Reverse Stock Split
StemCells, Inc. announced that stockholders voted to approve a reverse stock split of the Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis under the existing trading symbol "STEM." May 06, 2016